CureSureMedico
|
EN
Verified Partner
Shanghai · China·Founded in 2023

Shanghai GoBroad Cancer Hospital

First research-type hospital established in the Shanghai Free Trade Zone

Licensed Class 3 specialty hospital (2023)
View Treatments
Shanghai GoBroad Cancer Hospital — Shanghai

About

Shanghai GoBroad Cancer Hospital, part of GoBroad Healthcare Group, opened in October 2023 in the Shanghai (Waigaoqiao) Free Trade Zone as the zone's first research-type hospital. The 406-bed Phase I facility (with a further expansion to roughly 700 beds planned by 2026) specialises in solid-tumour oncology, including digestive cancers, bone and soft-tissue sarcoma, and lung cancer, alongside cellular and targeted-therapy programmes.

Recognition & Awards

  • First research-type hospital established in the Shanghai Free Trade Zone

Free guidance

Plan your treatment

Our coordinators match you to the right specialist, arrange your itinerary, and stay with you through recovery — at no cost.

or message us on WhatsApp

No commitment required. Your data is never shared.

At a glance

Hospital overview

calendar_today

2023

Year founded

Over 3 years of experience

bed

406+

Hospital beds

Including ICU and specialised units

verified

1

Accreditations

Licensed Class 3 specialty hospital (2023)

Medical expertise

Specialties at Shanghai GoBroad Cancer Hospital

Click a specialty to browse related treatments and cost comparisons.

Quality assurance

Accreditations & Certifications

Accreditations represent independent verification that this hospital meets internationally recognised standards for patient safety, clinical outcomes, and quality management.

Licensed Class 3 specialty hospital (2023)

Questions & answers

Frequently asked questions

Click 'Get a Quote' and complete the short form. A CureSureMedico coordinator will contact you within 48 hours with pricing, specialist availability, and next steps — at no charge to you.

Explore more

Other hospitals in the same region

Ruijin Hospital

Ruijin Hospital

Shanghai, China

Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, was founded in 1907 and has grown into a leading Class 3A academic medical centre with close to 2,800 beds across three campuses in Shanghai. It is internationally recognised in haematology: physician-scientists at Ruijin — including Wang Zhenyi, Chen Zhu, and Chen Saijuan — developed the combined all-trans retinoic acid (ATRA) and arsenic trioxide therapy for acute promyelocytic leukaemia, raising five-year survival from roughly 10% to over 97% and reshaping leukaemia treatment worldwide. The hospital completed a DNV DIAS international accreditation audit in 2025, recognised by insurers in more than 130 countries, and also maintains strong programmes in endocrinology and minimally invasive gastrointestinal surgery.

Class 3A (三级甲等)DNV DIAS International Acc…
View Profile
Peking University People's Hospital

Peking University People's Hospital

Beijing, China

Peking University People's Hospital opened in 1918 as Peking Central Hospital, the first general hospital in China to be entirely Chinese-financed and Chinese-run, and today serves as the Second Clinical Medical School of Peking University with over 2,600 beds and 1,300 physicians across its campuses. Its Institute of Hematology, established in 1981, is where academician Lu Daopei performed China's first successful allogeneic bone marrow transplant and has ranked first nationally in haematology for eleven consecutive years. The hospital's orthopaedics department, founded in 1944 by Feng Chuanhan — founder of the Chinese Orthopaedic Association — operates one of the largest bone tumour centres of its kind internationally.

Class 3A (三级甲等)

1,300+

Specialists

2,600+

Beds

View Profile
Shanghai Tongji Hospital

Shanghai Tongji Hospital

Shanghai, China

Shanghai Tongji Hospital is a Class 3A teaching hospital affiliated with Tongji University School of Medicine, operating close to 1,300 beds across its Putuo District campus in Shanghai. It holds municipal top-priority discipline status in orthopaedics and in psychiatry and neurology, with additional recognised strengths in cardiology, spine surgery, psychosomatic medicine, and gastroenterology.

Class 3A (三级甲等)

1,300+

Beds

View Profile

No fees. No commitment.

Ready to plan your treatment?

We are compensated by our partner hospitals — never by patients. You get independent clinical matching, full cost transparency, and end-to-end coordination at no cost to you.

Message us on WhatsApp